Results 281 to 290 of about 301,445 (291)

Advanced drug delivery and targeting technologies for the ocular diseases

BioImpacts, 2016
Yadollah Omidi, Ayuob Aghanejad, Marziyeh Fathi   +2 more
exaly  

The impact of brain tumors on vision and ocular motility

Journal of American Association for Pediatric Ophthalmology and Strabismus, 2015
Robert A. Avery, Stacy L. Pineles, Gena Heidary, Jane C. Edmond   +3 more
openaire   +2 more sources

Chlamydia psittaci is variably associated with ocular adnexal MALT lymphoma in different geographical regions

Journal of Pathology, 2006
Chun-te Wu
exaly  

Fundamentals, challenges, and nanomedicine‐based solutions for ocular diseases

Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology, 2019
Dadi A Srinivasarao, Dhirendra S Katti
exaly  

Understanding, recognizing, and managing toxicities of targeted anticancer therapies

Ca-A Cancer Journal for Clinicians, 2013
exaly  

Ocular blood flow in glaucoma – the Leuven Eye Study

Acta Ophthalmologica, 2016
Abraham Shibesh, Luís Abegão Pinto, Koen Willekens   +2 more
exaly  

A Vision for the Future of Pediatric Firearm-Related Ocular Trauma

JAMA Ophthalmology, 2019
Joseph V. Sakran, Fasika A. Woreta, Joseph K. Canner   +2 more
openaire   +3 more sources

Cancer Excision from Eyelids and Ocular Adnexa: The Mohs Fresh Tissue Technique and Reconstruction

Ca-A Cancer Journal for Clinicians, 1982
exaly  

Binocular Vision and Ocular Motility, 6th Edition

Journal of Neuro-Ophthalmology, 2003
openaire   +2 more sources

Pegaptanib, a targeted anti-VEGF aptamer for ocular vascular disease

Nature Reviews Drug Discovery, 2006
exaly